Sheikh Khalifa Medical City Hospital,
Abu Dhabi, UAE
Dr Farhan Fazal is an infectious disease doctor working at the Sheikh Khalifa Medical City Hospital in Abu Dhabi. He trained in internal medicine and has an infectious disease fellowship from the prestigious All India Institute of Medical Sciences, Delhi. Dr Fazal is also a fellow of the Royal College of Pathologists, UK. He was part of the COVID-19 expert committee in his home town during the COVID-19 pandemic and played a vital part in promoting COVID-19 guidelines and vaccination to healthcare workers and the public. read more
Dr Fazal is a passionate teacher and considers teaching young doctors about responsible use of antibiotics a vital part in the fight against antimicrobial resistance. He has many national and international publications to his credit. He has been invited as a speaker to many infectious disease and internal medicine conferences. His areas of interest are infections in immunocompromised patients and tropical infections, with a special focus on haemophagocytic lymphohistiocytosis.
Dr Farhan Fazal has no interests/relationships or affiliations to disclose in relation to this activity.
American University of Beirut, Beirut, Lebanon
Dr Nada Melhem is an associate professor of infectious diseases and microbiology (virology and immunology) at the Faculty of Health Sciences, American University of Beirut. Dr Melhem is currently the director of the Division of Health Professions and the chair of the Medical Laboratory Sciences Program at the Faculty of Health Sciences. read more
Dr Melhem has developed a transdisciplinary and translational research programme addressing viral immunopathogenesis and the epidemiology of viruses, and their impact on global human health. Dr Melhem’s research programme focuses on HIV type 1 and viral diarrhoeal diseases, specifically noroviruses and COVID-19. Dr Melhem is currently leading the SARS-CoV-2 National Surveillance Genomic Program for healthcare workers and hospitalized patients.
Dr Melhem is an elected council member of the International Society for Infectious Diseases. She is also a member of the National Committee for Communicable Diseases, serving as a scientific advisor to the minister of public health and the director general of the ministry in Lebanon. Dr Melhem serves as a member of the National COVID-19 Crisis Management Committee in Lebanon, the WHO COVID-19 Epidemiology Technical Advisory Group and the SARS-CoV-2 Evolution Technical Advisory Group. She is also the representative of low-resource settings on rapid evidence assessment of drug candidates of the COVID-19 Clinical Research Coalition. Since the beginning of the COVID-19 pandemic, Dr Melhem has served on the COVID-19 Expert Committee at the American University of Beirut.
Dr Nada Melhem has no interests/relationships or affiliations to disclose in relation to this activity.
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic. The impact on the medical community has been huge, not only on the front line of medical care but also for those navigating patient treatment during this unprecedented situation.
The touchINFECTIOUS DISEASES expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
